[Evaluating the efficacy of a new drug].
To give a practical guide for phase III clinical trial reading in order to evaluate independently the efficacy of a (new) drug therapy. Synthesis established by public health teachers and illustrated with examples in the field of urology. A structured and simplified critical review of clinical trial remains the main way to "have an idea" of a new drug efficacy. Efficacy in clinical trial may be far from patient satisfaction, willingness to pursue with this treatment or cost-effectiveness relevance. Knowledge of patient expectation, disease evolution and epidemiology have to be put side by side to raw efficacy data coming from phase III study in order to evaluate efficiency and effectiveness of new drugs therapy.